Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study

BACKGROUND: This study was conducted to evaluate the feasibility of long-term adalimumab (ADA) discontinuation after achievement of low disease activity (LDA) in Japanese patients with early rheumatoid arthritis (RA) and to identify predictors of LDA maintenance. METHODS: In the HOPEFUL-1 study, pat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Arthritis Res Ther
Huvudupphovsmän: Tanaka, Yoshiya, Yamanaka, Hisashi, Ishiguro, Naoki, Miyasaka, Nobuyuki, Kawana, Katsuyoshi, Kimura, Junko, Agata, Naoki, Takeuchi, Tsutomu
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2017
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5348900/
https://ncbi.nlm.nih.gov/pubmed/28288682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1264-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk